NCT00118326View on ClinicalTrials.gov

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2003

Study Completion Date

May 31, 2007

Conditions
Kidney CancerLeukemiaLymphomaMyelodysplastic SyndromesNeuroblastomaSarcoma
Interventions
BIOLOGICAL

filgrastim

PROCEDURE

allogeneic bone marrow transplantation

Trial Locations (2)

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
lead

Fred Hutchinson Cancer Center

OTHER

NCT00118326 - Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease | Biotech Hunter | Biotech Hunter